We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery

News   Sep 14, 2018 | Original story from Optibrium

 
Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery
 
 
Advertisement
 

RELATED ARTICLES

Artificial Intelligence Cracks a 50-Year-Old Problem in Protein Biology

News

The UK-based company DeepMind has arguably solved one of the greatest challenges that biology has faced for several decades – the "protein folding problem" – using an AI system known as AlphaFold.

READ MORE

Risk of Pre-Eclampsia Related to Blood Pressure and BMI

News

New research has revealed that the genetic risk of pre-eclampsia is related to blood pressure and body mass index.

READ MORE

Addressing the Plastic Polution Crisis With Chemistry and AI

News

Researchers are developing a novel set of tools that aim to reduce plastic waste and production.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE